Senseonics and TypeZero's R&D partnership around the artificial pancreas is leveling up. The two organizations announced today that they would team up with pharmaceutical and medical device company Roche to launch three European clinical trials of their combined closed-loop system. The research is backed by the National Institutes of Health (NIH) through its International Diabetes Closed Loop...
With all the recent technological approaches to clinical trials as of late, it’s clear that the notoriously long, expensive and often inefficient traditional process could use an update. From AI-powered matching platforms to increasingly sophisticated software to streamline data collection during trials, the space is getting busier.
Palo Alto-based monARC Bionetworks is one of the latest to make...
The relationship between global pharmaceutical company Roche and digital diabetes management app maker mySugr has been growing for the past couple of years. First there was the investment, then there was the partnership, and now Roche is going all in and becoming the exclusive shareholder of mySugr.
Under the agreement, mySugr will continue to function as a separate legal entity, but will serve...
Vienna and San Diego-based digital health company mySugr has come out of the International Conference on Advanced Technologies and Treatments for Diabetes with two big pieces of news: study results that show impressive efficacy of the app in high-risk populations and an expansion of its partnership with Roche.
The study looked at 440 mySugr users randomly selected from a group of high-risk (HbA1C...
Roche has selected two health technology companies to deploy a wireless wearable system in a clinical trial on a drug for infants with spinal muscular atrophy.
The study will use BioRadio, a wireless wearable data acquisition system from Great Lakes NeuroTechnologies that records respiratory and pulmonary data from infants in near real time. Vivonoetics’ VivoSense software works in collaboration...
Madison, Wisconsin-based Propeller Health, which offers a digitally-guided respiratory therapy platform, has teamed up with Medical International Research (MIR) to offer several of the Italian health technology company’s mobile and clinical spirometers alongside the Propeller system. The addition of sprirometers will give Propeller a more complete vision of the people using their platform, which...
Germantown, Maryland-based Senseonics, which is working on a long-term implantable continuous glucose monitor called Eversense, has expanded its exclusive distribution agreement with Roche.
Now, Roche will have exclusive rights to promote, market and sell the Eversense product line to diabetes clinics and patients in in most of Europe (excluding Scandinavia and Finland), the Middle East (except...
Austria and San Diego-based mySugr has added coaching to the premium version of its mySugr Logbook app, the company announced this week.
"What we want to do is create a digital diabetes clinic," North American Managing Director Kyle J. Rose said today at the Digital Medicine Connect event in Boston. "What we’ve decided to do is actually work with diabetes educators as coaches. Because, as...
Roche Diagnostics has launched a Bluetooth-connected device for testing blood coagulation in Europe. The CoaguChek INRange system has received a CE Mark, and an older version of the device without the Bluetooth connectivity is already available in the US and in Europe.
The Bluetooth connectivity allows patients undergoing Vitamin K antagonist therapy to self-monitor their blood coagulation with a...
About a year after pharmaceutical company Roche announced an investment in diabetes app company mySugr, the companies announced an integration partnership.
MySugr offers a handful of apps, but its flagship is called Diabetes Logbook, which is designed for people with type 1 or type 2 diabetes and includes logging, graphing, analysis, and Apple Health integration. If users sign up for a month-to-...
.jpeg?itok=HF3iI7dj "Person answering their front door and getting a delivery from another person")
